from MD Anderson Cancer Center1 year agoAfter Paul McKinney was diagnosed with stage III melanoma, he enrolled in a clinical trial, where he received a new immunotherapy combination testing an LAG-3 antibody. Read at MD Anderson Cancer Center[add][|| ... ]